Ketamine Infusion Dosing for Adult Patients
For a typical adult patient with no significant medical history requiring ketamine infusion for pain management, administer a 0.5 mg/kg IV bolus followed immediately by a continuous infusion of 1-2 μg/kg/min (0.06-0.12 mg/kg/hr), with a maximum infusion rate of 0.5 mg/kg/hr. 1, 2
Standard Dosing Protocol
Initial Bolus Dose
- Administer 0.5 mg/kg IV bolus as the loading dose 1, 2
- This dose provides effective analgesia while minimizing psychotropic side effects 2
- The bolus should be given slowly over 60 seconds to avoid respiratory depression and enhanced vasopressor response 3
Continuous Infusion
- Start infusion immediately after the bolus at 1-2 μg/kg/min (equivalent to 0.06-0.12 mg/kg/hr) 1, 2
- Maximum infusion rate is 0.5 mg/kg/hr 2
- For ICU patients, the range of 0.5-2 mg/kg/hr has been used, though lower doses are preferred 2
Preparation and Administration
- For maintenance infusions: Dilute 10 mL from a 50 mg/mL vial (or 5 mL from a 100 mg/mL vial) into 500 mL of normal saline or 5% dextrose to create a 1 mg/mL solution 3
- Use immediately after dilution 3
- When fluid restriction is required, add to 250 mL to provide a 2 mg/mL concentration 3
Clinical Efficacy and Outcomes
Pain Reduction
- Low-dose ketamine infusions reduce overall opioid requirements by approximately 22 mg morphine equivalents without increasing side effects 2
- At 10 minutes post-administration, median pain reduction is 4 points on the numerical rating scale 4
- By 60 minutes, approximately 66% of patients report clinically significant pain reduction (>3 point decrease) 4
Duration of Effect
- Average total sedation time with IV ketamine is approximately 75-78 minutes 1
- Recovery time averages 84 minutes 1
Administration Rate Considerations
Administer the 0.3 mg/kg dose as a slow infusion over 15 minutes rather than IV push to significantly reduce bothersome side effects while maintaining equivalent analgesia. 5
- Slow infusion (15 minutes) reduces moderate or greater psychoperceptual side effects from 75.9% to 43.4% compared to IV push 5
- Hallucinations occur in 27.6% with IV push versus only 6.7% with slow infusion 5
- Analgesic efficacy remains equivalent between administration methods 5
Monitoring Requirements
Essential Vital Sign Monitoring
- Continuous monitoring of oxygen saturation, heart rate, blood pressure, and respiratory status is mandatory 2, 3
- Vital signs should be documented at least every 5 minutes during deep sedation 1
- Emergency airway equipment must be immediately available 3
Hemodynamic Effects
- Transient increases in blood pressure, heart rate, and cardiac index frequently occur 3
- Heart rate and blood pressure typically remain stable during low-dose infusions 4
- Ketamine maintains cardiovascular stability through central NMDA blockade and preserved adrenal function 2, 6
Side Effects Profile
Common Adverse Effects
- Psychoperceptual effects (dizziness, fatigue, headache) are common but mostly mild 4
- Approximately 70-86% of patients experience some psychoperceptual side effect 5
- Sedation is the predominant side effect in multiple studies 2
Minimizing Psychotropic Effects
- Co-administer benzodiazepines (such as midazolam 0.05-0.1 mg/kg) to minimize dysphoria, nightmares, and hallucinations 2, 3
- Psychotomimetic effects are dose-dependent and occur especially at higher doses and with prolonged use 2
Respiratory Considerations
- Hypoxemia occurs in 1.6-7.3% of patients, typically transient and responsive to supplemental oxygen 1
- Bag-valve-mask ventilation required in approximately 2% of cases 1
- Some degree of airway protection is afforded due to active laryngeal-pharyngeal reflexes 3
Absolute Contraindications
Do not use ketamine in patients with: 2, 3
- Uncontrolled cardiovascular disease or conditions where significant blood pressure elevation would constitute a serious hazard
- Known hypersensitivity to ketamine
- Pregnancy
- Active psychosis
- Severe hepatic dysfunction
- Elevated intracranial or intraocular pressure
Special Clinical Scenarios
Hemodynamically Unstable Patients
- For patients in shock, ketamine remains a reasonable choice due to cardiovascular stability maintenance 6
- Start at the lower end of the dosing range (0.5 mg/kg bolus, 1 μg/kg/min infusion) and titrate carefully 6
- Use caution as ketamine can still suppress myocardial contractility in patients with depleted catecholamine reserves 6
Patient Satisfaction
- 85% of patients report they would have ketamine again for similar pain 4
- High satisfaction rates despite common mild side effects 4
Key Clinical Pitfalls to Avoid
- Never administer the 100 mg/mL concentration IV without proper dilution - this is a critical safety issue 3
- Do not use in patients who have not followed nil per os guidelines due to aspiration risk 3
- Avoid rapid IV administration as it results in respiratory depression and enhanced vasopressor response 3
- Do not continue ketamine infusions into the postoperative period as this increases hallucination risk without significantly improving analgesia 2